glp-1 drugs pcos for PCOS: Is It the Right Choice? The Role of Glp-1 Receptor

aHR, adjusted hazard ratio

Diabetes Care 43 , 13521355 (2020)

DPP-IV modulates diverse cellular processes including survival, proliferation, and differentiation, and thereby enhances or diminishes tumorigenesis depending on the types or phases of tumors (Havre et al., 2008)

[DOI] [PMC free article] [PubMed] [Google Scholar] 98.Mishra R, Raj R, Elshimy G, Zapata I, Kannan L, Majety P, et al

In addition to reducing food noise, her primary goal is to lower inflammation in patients with autoimmune conditions

Abstract Background: The benefit of first-line use of sodium-dependent glucose transport 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 2 diabetes mellitus (T2DM) with low risk of cardiovascular diseases are not clear